Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Incidence and Timing of Thromboembolic Events in Patients With Ovarian Cancer Undergoing Neoadjuvant Chemotherapy

Greco, Patricia S.; Bazzi, Ali A.; McLean, Karen; Reynolds, R. Kevin; Spencer, Ryan J.; Johnston, Carolyn M.; Liu, J. Rebecca; Uppal, Shitanshu

Obstetrical & Gynecological Survey: September 2017 - Volume 72 - Issue 9 - p 537–538
doi: 10.1097/OGX.0000000000000480
GYNECOLOGY: GYNECOLOGIC ONCOLOGY
Buy

(Abstracted from Obstet Gynecol 2017;129(6):979–985)

Thromboembolism in patients with ovarian and other cancers is associated with lower survival and poor quality of life. The estimated incidence of venous thromboembolism (VTE) among patients with ovarian cancer (OC) is 10% to 22%.

Division of Gynecologic Oncology and Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor; Department of Obstetrics and Gynecology, St John Hospital, Detroit, MI; and Division of Gynecologic Oncology, University of Wisconsin, Madison, WI

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.